Funding

Slate Medicines

United States · Biotech · Healthtech

Advancing next-generation therapeutics for migraine and other headache disorders

Visit slatemedicines.comFunding history

Funding history

1 round · 1 with disclosed amounts
AnnouncedRoundAmountInvestors
Series A$130MForbion — Role not disclosedForesite Capital — Role not disclosedRA Capital Management — Role not disclosed

Investors

ForbionSeries AForesite CapitalSeries ARA Capital ManagementSeries A

Coverage

Feb 24, 2026Slate Medicines · Series A

Similar companies

Guoke Brain-ComputerBeijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.Undisclosed · Seed
Pathos AIClinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.$237M · Series E
Star TherapeuticsBiotechnology company discovering and developing antibody therapies for diseases with significant unmet need.$200M · Private financing
Sourcesslatemedicines.com ↗